~10 spots leftby May 2026

Psychodynamic Psychotherapy for PTSD

(RCT of TFPP Trial)

Recruiting in Palo Alto (17 mi)
BM
Overseen byBarbara L Milrod, MD
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Recruiting
Sponsor: Montefiore Medical Center
Must be taking: Psychiatric medications
Disqualifiers: Psychotic disorder, Bipolar, Substance use, others
No Placebo Group

Trial Summary

What is the purpose of this trial?

This trial tests a new talk therapy called TFPP for veterans with PTSD who haven't been helped by current treatments. TFPP helps veterans understand and process their trauma through structured conversations, aiming to improve their overall mental health.

Will I have to stop taking my current medications?

The trial requires participants to be stable on their psychiatric medications for at least 2 months before joining, so you should not stop taking your current medications.

What data supports the effectiveness of the treatment Trauma-Focused Psychodynamic Psychotherapy (TFPP) for PTSD?

Research suggests that Trauma-Focused Psychodynamic Psychotherapy (TFPP) can be effective for PTSD by addressing emotional and psychological issues related to trauma, as seen in studies involving veterans and LGBTQ individuals. This therapy helps patients understand and process their traumatic experiences, which can reduce PTSD symptoms.12345

Is Trauma-Focused Psychodynamic Psychotherapy (TFPP) safe for treating PTSD?

The available research on Trauma-Focused Psychodynamic Psychotherapy (TFPP) for PTSD does not specifically mention safety concerns, suggesting it is generally considered safe for use in humans.13678

What makes Trauma-Focused Psychodynamic Psychotherapy (TFPP) unique for treating PTSD?

Trauma-Focused Psychodynamic Psychotherapy (TFPP) is unique because it explores the psychological meanings of PTSD symptoms and their relation to traumatic events, focusing on narrative coherence and emotional regulation. It also incorporates identity-related and societal factors, making it particularly beneficial for LGBTQ individuals seeking affirmative care.134910

Research Team

BM

Barbara L Milrod, MD

Principal Investigator

Weill Medical College of Cornell University

Eligibility Criteria

This trial is for Veterans with moderate PTSD (CAPS score >40) who haven't improved after standard VA treatments. They must have stable psychiatric meds for 2 months and a history of not responding well to certain PTSD therapies. It's not for those with severe suicidality, psychosis, bipolar disorder, substance issues that affect participation, or unstable medical conditions.

Inclusion Criteria

I have moderate PTSD with a CAPS score over 40.
I have been stable on my psychiatric medication for at least 2 months.
I have tried or was deemed unsuitable for CPT/PE therapy but still have symptoms.

Exclusion Criteria

You have very strong suicidal thoughts that need immediate attention and help.
I am able to participate in all required trial activities.
I do not have any mental or unstable health conditions that would affect my participation.
See 1 more

Trial Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive Trauma-Focused Psychodynamic Psychotherapy (TFPP) or Treatment as Usual (TAU) for PTSD

16 weeks
16-24 sessions (in-person)

Follow-up

Participants are monitored for changes in PTSD symptoms and other psychological measures

3 months

Treatment Details

Interventions

  • TAU (Behavioural Intervention)
  • Trauma-Focused Psychodynamic Psychotherapy (TFPP) (Psychodynamic Psychotherapy)
Trial OverviewThe study tests Trauma-Focused Psychodynamic Psychotherapy (TFPP) against Treatment as Usual (TAU) at the VA in a randomized controlled setup. Of the 75 participants, two-thirds will receive TFPP and one-third TAU to see which helps more with PTSD symptoms.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: TFPPExperimental Treatment1 Intervention
TFPP is a manualized 16-24 session psychodynamic psychotherapy targeted on trauma symptoms of PTSD
Group II: TAUActive Control1 Intervention
TAU in this study is treatment for PTSD as currently delivered at the VA

Find a Clinic Near You

Research Locations NearbySelect from list below to view details:
VA New York Harbor Healthcare System - Manhattan CampusNew York, NY
Loading ...

Who Is Running the Clinical Trial?

Montefiore Medical Center

Lead Sponsor

Trials
468
Recruited
599,000+
Andrew D. Racine profile image

Andrew D. Racine

Montefiore Medical Center

Chief Medical Officer since 1992

MD, PhD from New York University; Undergraduate degree from Harvard University

Philip O. Ozuah profile image

Philip O. Ozuah

Montefiore Medical Center

Chief Executive Officer since 2019

MD, PhD from New York University

Weill Medical College of Cornell University

Lead Sponsor

Trials
1103
Recruited
1,157,000+
Dr. Robert Min profile image

Dr. Robert Min

Weill Medical College of Cornell University

Chief Executive Officer since 2024

MD, MBA

Dr. Adam R. Stracher profile image

Dr. Adam R. Stracher

Weill Medical College of Cornell University

Chief Medical Officer since 2024

MD

International Psychoanalytic Association (IPA)

Collaborator

Trials
1
Recruited
80+

National Center for Advancing Translational Sciences (NCATS)

Collaborator

Trials
394
Recruited
404,000+
Dominique C. Pichard profile image

Dominique C. Pichard

National Center for Advancing Translational Sciences (NCATS)

Chief Medical Officer since 2023

MD

Joni L. Rutter profile image

Joni L. Rutter

National Center for Advancing Translational Sciences (NCATS)

Chief Executive Officer since 2022

PhD in Pharmacology

Weill Medical College Clinical Science Translation Center

Collaborator

Trials
1
Recruited
80+

American Psychoanalytic Association (APsA)

Collaborator

Trials
1
Recruited
80+

International Psychoanalytic Association

Collaborator

Trials
1
Recruited
80+

VA New York Harbor Healthcare System

Collaborator

Trials
25
Recruited
14,400+

CTSC

Collaborator

Trials
1
Recruited
80+

American Psychoanalytic Association Fund for Psychoanalytic Research

Collaborator

Trials
1
Recruited
80+

Findings from Research

Trauma-focused psychotherapy (TF-P) significantly reduced PTSD symptoms, depressive symptoms, and functional impairment in patients with complex post-traumatic stress disorder (CPTSD) compared to those who only received stabilization and waiting, based on a study of 59 patients over a 3-year period.
The study found no significant differences in outcomes between the specific types of TF-P treatments (like TF-CBT or EMDR), indicating that the overall approach of TF-P is effective regardless of the specific method used.
The effectiveness of trauma-focused psychotherapy for complex post-traumatic stress disorder: A retrospective study.Melegkovits, E., Blumberg, J., Dixon, E., et al.[2023]
Trauma-focused psychodynamic psychotherapy effectively addresses PTSD by exploring the psychological meanings behind symptoms and their connections to traumatic events, helping patients regain narrative coherence.
The therapy utilizes the therapeutic relationship to work through feelings of mistrust, authority issues, and intense emotions, providing a structured approach to understanding and managing PTSD symptoms.
Trauma-Focused Psychodynamic Psychotherapy.Busch, FN., Milrod, BL.[2019]
A mobile phone-delivered serious game designed to enhance trauma-focused cognitive behavioral therapy (TF-CBT) for PTSD was found to be acceptable to both patients and clinicians, indicating potential for improved treatment engagement.
Both service users and clinicians suggested that the game should be therapist-guided and acknowledged that it may not be suitable for all patients, emphasizing the need for careful prescription by clinicians.
Acceptability of a Plasticity-Focused Serious Game Intervention for Posttraumatic Stress Disorder: User Requirements Analysis.Jones, M., Denisova, A., Mitchell, S., et al.[2020]

References

Open Trial of Trauma-Focused Psychodynamic Psychotherapy for Posttraumatic Stress Disorder Among LGBTQ Individuals. [2023]
The effectiveness of trauma-focused psychotherapy for complex post-traumatic stress disorder: A retrospective study. [2023]
Trauma-Focused Psychodynamic Psychotherapy of a Patient With PTSD in a Veterans Affairs Setting. [2019]
Trauma-Focused Psychodynamic Psychotherapy. [2019]
Acceptability of a Plasticity-Focused Serious Game Intervention for Posttraumatic Stress Disorder: User Requirements Analysis. [2020]
The Development of Transference-Focused Psychotherapy and Its Model of Supervision. [2023]
Comparing trauma-focused cognitive-behavioral therapy to commonly used treatments in usual care for children with posttraumatic stress disorder. [2023]
[Trauma-focused Cognitive-behavioral Therapy with children and adolescents: Practice, evidence base, and future directions]. [2018]
Transference-focused psychotherapy in the general psychiatry residency: a useful and applicable model for residents in acute clinical settings. [2019]
10.United Statespubmed.ncbi.nlm.nih.gov
The place of psychodynamic psychotherapy in the integrated treatment of posttraumatic stress disorder and trauma recovery. [2011]